Skip to Main Content
Scroll to read more


To understand the zoonotic nature of SARS-CoV-2 and identify novel drugs to treat COVID-19, we investigated its entry receptor ACE2. We conducted a systematic analysis of the ACE2 conservation and co-evolution protein network across 1671 eukaryotes, revealing unexpected conservation patterns. We then mapped the co-evolved protein network and identified potential drugs that can target it.